VITREX MEDICAL A/S: Financial statements 2017
CVR: 14728732
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 22,491,140 and a net result of DKK 6,400,477 compared with DKK 5,078,120 the year before. That is an increase of 9.2% compared with the year before. Equity in the 2017 report amounted to DKK 22,085,932. The solvency ratio was 55.5%.
- Gross Profit
- DKK 22,491,140
- Profit/Loss
- DKK 6,400,477
- Equity
- DKK 22,085,932
- Total Assets
- DKK 39,811,892
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 22.5M | 6.4M | 22.1M | - |
| 2016 | - | 20.6M | 5.1M | 20.7M | - |
| 2015 | - | 21.2M | 6.2M | 20.6M | - |
| 2014 | - | 16M | 4.6M | 17.9M | - |
| 2013 | - | 14.7M | 3.9M | 13.3M | - |
Official annual report
Keep an eye on VITREX MEDICAL A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of July 1, 2017, Vagn Andersen has joined the board of directors of VITREX MEDICAL A/S.
As of July 1, 2017, Marek Herold has left the board of directors of VITREX MEDICAL A/S.
As of July 1, 2017, Anders Folkmar Pedersen is registered as adm. dir. of VITREX MEDICAL A/S.
As of July 1, 2017, Vagn Andersen has stepped down as adm. dir. of VITREX MEDICAL A/S.
VITREX MEDICAL A/S has published its annual report for 2016. Gross profit came to DKK 20,604,125, and the net result was DKK 5,078,120.
About VITREX MEDICAL A/S
VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.